# OnCo record graded-prognostic-assessment (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/graded-prognostic-assessment/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "graded-prognostic-assessment" ;
  schema:name "Graded Prognostic Assessment (GPA) for brain metastases"@en ;
  schema:alternateName "GPA"@en, "graded prognostic assessment"@en, "diagnosis-specific GPA"@en, "ds-GPA"@en, "DS-GPA"@en, "molecular GPA"@en, "Lung-molGPA"@en, "Melanoma-molGPA"@en, "Breast-GPA"@en, "RPA class"@en, "recursive partitioning analysis for brain metastases"@en, "brain metastases prognostic index"@en, "brain metastasis velocity"@en ;
  schema:description "The GPA is a points score (age, performance status, number of brain metastases, spread outside the brain, and for some cancers the tumour's mutations) that estimates survival for a patient with brain metastases from a few months to several years, and it is what oncologists use to decide whether aggressive local treatment like radiosurgery is worth it."@en ;
  schema:url <https://onco.cc/terms/graded-prognostic-assessment/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:related <https://onco.cc/terms/performance-status/>, <https://onco.cc/terms/brain-metastases/>, <https://onco.cc/terms/stereotactic-radiosurgery/>, <https://onco.cc/terms/radiotherapy/>, <https://onco.cc/drugs/osimertinib/>, <https://onco.cc/drugs/lorlatinib/> ;
  onco:cancers <https://onco.cc/cancers/secondary-brain-tumours/>, <https://onco.cc/cancers/her2-positive-breast-brain-metastases/> .